These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7228571)

  • 21. [Anemia in patients treated with periodic hemodialysis. Therapeutic criteria and long-term results].
    Bucciante G; Frizzi V; Bernardi AM; Amadori G
    Minerva Urol; 1978; 30(2):85-95. PubMed ID: 703731
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anemia of chronic renal insufficiency. II. Effect of androgen therapy in 17 subjects treated with periodic hemodialysis].
    Najean Y; Eberlin A; Delons S; Naret C; Petrover M; Aubert P
    Presse Med; 1983 Apr; 12(18):1159-61. PubMed ID: 6221284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
    Wanic-Kossowska M; Kazmierski M; Pawliczak E; Kobelski M
    Pol Arch Med Wewn; 2007; 117(1-2):14-9. PubMed ID: 17642201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.
    Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD
    Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anemia in chronic renal failure.
    Neff MS; Goldberg J; Slifkin RF; Eiser AR; Calamia V; Kaplan M; Baez A; Gupta S; Mattoo N
    Acta Endocrinol Suppl (Copenh); 1985; 271():80-6. PubMed ID: 3865483
    [No Abstract]   [Full Text] [Related]  

  • 27. [Renal anemia. Its diagnosis, pathogenesis, compensation and therapy in childhood].
    Müller-Wiefel DE
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):72-9. PubMed ID: 6374430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anemia and hormone therapy for patients on intermittent chronic hemodialysis].
    Matsuoka H; Tamura T
    Horumon To Rinsho; 1974 Aug; 22(8):951-4. PubMed ID: 4476258
    [No Abstract]   [Full Text] [Related]  

  • 29. [Guidelines for the treatment of anemia in chronic renal failure].
    Triolo G;
    G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of frequency of intravenous iron administration on hemoglobin variability in maintenance hemodialysis patients.
    Wan L; Zhang D
    Int Urol Nephrol; 2018 Aug; 50(8):1511-1518. PubMed ID: 29946818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anemia in kidney insufficiency, during chronic hemodialysis and following kidney transplantation].
    Schulz W
    Med Klin; 1975 May; 70(20):909-13. PubMed ID: 1094257
    [No Abstract]   [Full Text] [Related]  

  • 32. [Additional measures of treatment in patients with renal anemia].
    Belavić Z; Kupres V
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():62-8. PubMed ID: 20232553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral or parenteral iron therapy in haemodialysis patients?
    Winney RJ; Swainson CP; Parker AC; Bone JM; Robson JS
    Proc Eur Dial Transplant Assoc; 1977; 14():184-91. PubMed ID: 600955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of androgens in chronic renal failure patients on maintenance hemodialysis.
    Alexander MR
    Am J Hosp Pharm; 1976 Mar; 33(3):242-8. PubMed ID: 769543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of anemia caused by chronic kidney failure in adults].
    Nephrol Ther; 2005 Aug; 1 Suppl 1():S1-48. PubMed ID: 16895707
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anemia in chronic renal insufficiency].
    Feiman R; Mena Castro E; Gordillo Paniagua G
    Bol Med Hosp Infant Mex; 1981; 38(2):231-41. PubMed ID: 7259844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of testosterone on the anaemia of terminal renal failure (author's transl)].
    Augustin HJ; Kapaun W; Kötter C
    Dtsch Med Wochenschr; 1973 Nov; 98(45):2119-22. PubMed ID: 4757967
    [No Abstract]   [Full Text] [Related]  

  • 39. [Opatija study: observation of hemodialysis patients and titration of CERA dose just switched from another erythropoiesis stimulating agent].
    Jelić I; Lovcić V; Kurtović I; Josipović M; Havranek Z; Kostić L; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):157-64. PubMed ID: 23441529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Iron therapy in patients in the chronic intermittent hemodialysis program (CHIHP)].
    Chrobák L; Radochová D; Erben J; Strnad L; Rouchal J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(2):173-91. PubMed ID: 6975987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.